Friday, November 22, 2024
Facebook Linkedin Twitter
Home Tags MDN

MDN Related News

Why MDMA must be reclassified as a Schedule 2 drug

Why MDMA must be reclassified as a Schedule 2 drug

Amanda Feilding of the Beckley Foundation discusses the organisations new report ‘Roadmaps to Regulation: MDMA’ which recommends rescheduling MDMA to a Schedule 2 drug. MDMA...
© Pan European Networks Ltd

Pin It on Pinterest

UK OFFICE: +44 (0)1260 273 802
© 2018 - Published by Pan European Networks Ltd in Congleton, United Kingdom. - Co. Reg. No: 7652562
Disclaimer: www.healtheuropa.com is an independent portal and is not responsible for the content of external sites.
Please Note: Phone calls may be recorded for training and monitoring purposes.